International Journal of Molecular Sciences (Jul 2021)

LncRNA <i>MORT (ZNF667-AS1)</i> in Cancer—Is There a Possible Role in Gynecological Malignancies?

  • Riccardo Di Fiore,
  • Sherif Suleiman,
  • Rosa Drago-Ferrante,
  • Ana Felix,
  • Sharon A. O’Toole,
  • John J. O’Leary,
  • Mark P. Ward,
  • James Beirne,
  • Angel Yordanov,
  • Mariela Vasileva-Slaveva,
  • Yashwanth Subbannayya,
  • Francesca Pentimalli,
  • Antonio Giordano,
  • Jean Calleja-Agius

DOI
https://doi.org/10.3390/ijms22157829
Journal volume & issue
Vol. 22, no. 15
p. 7829

Abstract

Read online

Gynecological cancers (GCs) are currently among the major threats to female health. Moreover, there are different histologic subtypes of these cancers, which are defined as ‘rare’ due to an annual incidence of Mortal Obligate RNA Transcript (MORT; alias ZNF667-AS1) has been identified as a tumor-related lncRNA. ZNF667-AS1 gene, located in the human chromosome region 19q13.43, has been shown to be silenced by DNA hypermethylation in several cancers. In this review, we report on the biological functions of ZNF667-AS1 from recent studies and describe the regulatory functions of ZNF667-AS1 in human disease, including cancer. Furthermore, we discuss the emerging insights into the potential role of ZNF667-AS1 as a biomarker and novel therapeutic target in cancer, including GCs (ovarian, cervical, and endometrial cancers).

Keywords